Nektar Therapeutics is a clinical-stage biopharmaceutical company focused on immunotherapy drug discovery and development. Its pipeline targets autoimmune diseases and cancer through immunomodulatory agents. Key candidates include rezpegaldesleukin (targeting Treg cells for autoimmune disorders like atopic dermatitis and alopecia areata), NKTR-0165/0166 (preclinical autoimmune), and NKTR-255 (oncology). The company owns full rights to rezpegaldesleukin following termination of a prior Eli Lilly licensing agreement in 2023.
expected 2026-12-25
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001193125-26-104547 | EDGAR | 74K words |
| 2025-03-14 | 2024-12-31 | 0000950170-25-039389 | EDGAR | 99K words |
| 2024-03-05 | 2023-12-31 | 0000950170-24-026249 | EDGAR | 68K words |
| 2023-02-28 | 2022-12-31 | 0000906709-23-000004 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000906709-22-000005 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0000906709-21-000005 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0000906709-20-000004 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001564590-19-005639 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001564590-18-004105 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001564590-17-003064 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001193125-26-349805 | EDGAR | 41K words |
| 2025-11-07 | 2025-09-30 | 0001193125-25-270230 | EDGAR | 45K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105275 | EDGAR | 44K words |
| 2025-05-09 | 2025-03-31 | 0000950170-25-067279 | EDGAR | 39K words |
| 2024-11-08 | 2024-09-30 | 0000950170-24-123570 | EDGAR | 41K words |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094231 | EDGAR | 38K words |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057312 | EDGAR | 35K words |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060475 | EDGAR | 41K words |
| 2023-08-09 | 2023-06-30 | 0000906709-23-000012 | EDGAR | 38K words |
| 2023-05-10 | 2023-03-31 | 0000906709-23-000008 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0000906709-22-000019 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0000906709-22-000014 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001213900-26-103215 | EDGAR | 1K words |
| 2026-09-08 | 0001213900-26-098042 | EDGAR | 1K words |
| 2026-08-13 | 0001213900-26-089137 | EDGAR | 3K words |
| 2026-03-12 | 0001213900-26-027026 | EDGAR | 4K words |
| 2026-02-13 | 0001193125-26-049378 | EDGAR | 1K words |
| 2026-02-10 | 0001193125-26-044751 | EDGAR | 1K words |
| 2026-02-10 | 0001193125-26-043755 | EDGAR | 6K words |
| 2026-01-27 | 0001213900-26-008210 | EDGAR | 1K words |
| 2025-12-16 | 0001193125-25-320009 | EDGAR | 5K words |
| 2025-11-21 | 0001213900-25-113606 | EDGAR | 1K words |
235 total filings indexed. 203 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000906709 |
| Ticker | NKTR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.nektar.com |
| Listed | 1994-05-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NKTR (~200 tokens, structured JSON with cryptographic provenance)